Trial Profile
Bioequivalence of 80 mg Telmisartan/12.5 mg HCTZ Fixed Dose Combination Compared With Its Monocomponents in Healthy Male Volunteers II (an Open-label, Randomised, Single-dose, Two-sequence, Four-period Replicated Crossover Study)
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 22 Oct 2014
Price :
$35
*
At a glance
- Drugs Telmisartan/hydrochlorothiazide (Primary) ; Hydrochlorothiazide; Telmisartan
- Indications Hypertension
- Focus Pharmacokinetics
- Sponsors Boehringer Ingelheim
- 22 Oct 2014 New trial record